COA KVR-2026-E38080-S204 matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
N32EB6QLabel 60 mg · Lab measured 64.12 mg
107% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 16 mg using the measured mass, against 15 mg on the label — 7% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-E38080-S204 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tirzepatide, performed by Kovera Labs on June 4, 2026. Reported purity: 99.77%. Net content: 64.12 mg against 60 mg labeled (107% of label). Endotoxins: PASS (<=0.5 EU/mL). Heavy metals: Pass - As, Cd, Pb, Hg Negative. Batch BA060526TZ60. Sample source: shop-provided. Certificate of analysis attached.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion